Pharma Calls Out One of its Own

It’s not often that an association publicly disagrees with someone in the industry it represents. But the uproar over Turing Pharmaceuticals CEO Martin Shkreli jacking up the price of a life-saving drug 4,000% prompted this tweet from the Pharmaceutical Research and Manufacturers of America. The organization has been known to protect its own during a controversy, but in this case, the CEO’s unapologetic public comments hit a nerve. The tweet inspired even more backlash from people questioning why drugs are so expensive. [WaPo]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Washington, D.C. Newsletters
Related Stories

Salesforce Plans Innovation Hub Downtown: The D.C. Deal Sheet

Master Plan Is Underway For Southwest D.C., Chief Federal Planner Says

BXP Execs See Better Returns In Building Offices Than Buying Them

The Las Vegas-Style Sphere Just Outside D.C. Is A Go

The 'Zombie' Building Mirage: How Owners Who Can't Transact Are Stirring The Market

Coffee Shop Signs Lease At Downtown Trophy: The D.C. Deal Sheet

Denver Public Schools' $11M Centennial Hall Purchase Marks Rare Land Sale For ULC

Oliver Carr Jr.'s Firm Sells Alexandria Project To His Son's Company

Bill Barr's Law Firm Expands Footprint In Move To Pennsylvania Avenue

Amazon Ditches Ashburn Data Center Plan, Shifts To Mixed-Use Vision

Bowser Wants To Lock In A $550M Spa Before She Leaves. D.C. Council Members Are Pushing Back

Downtown Conversion Lands Construction Loan: The D.C. Deal Sheet